Evaluation of 4 Factor PCC Utilization
Linda Kelly, MD, Presbyterian Healthcare Services, discusses a drug utilization evaluation of a new 4 factor PCC product in her institution. Her evaluation found that in approximately 25% of patients treated with the product, concomitant vitamin K was not given as appropriate. This prompted the institution to change their electronic order system to better align vitamin k dosing and administration with a physician order of 4 factor PCC. Data collection is ongoing to ensure the dosing recommendations are followed and vitamin k is being dosed appropriately.